Cohen & Steers Stock Price, News & Analysis (NYSE:CNS)

1 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Cohen & Steers in the last year. There are currently 1 buy rating for the stock. The consensus among Wall Street analysts is that investors should "buy" CNS shares.
View CNS analyst ratings or view top-rated stocks.

1 equities research analysts have issued 12-month target prices for Cohen & Steers' shares. Their CNS share price targets range from $68.00 to $68.00. On average, they expect the company's stock price to reach $68.00 in the next twelve months. This suggests a possible upside of 16.6% from the stock's current price.
View analysts price targets for CNS or view top-rated stocks among Wall Street analysts.

Cohen & Steers' stock was trading at $64.56 at the beginning of 2023. Since then, CNS shares have decreased by 9.6% and is now trading at $58.34.
View the best growth stocks for 2023 here.

Cohen & Steers saw a decline in short interest during the month of November. As of November 15th, there was short interest totaling 1,740,000 shares, a decline of 6.5% from the October 31st total of 1,860,000 shares. Based on an average trading volume of 154,000 shares, the short-interest ratio is currently 11.3 days. Currently, 6.9% of the company's shares are sold short.
View Cohen & Steers' Short Interest.

The company is scheduled to release its next quarterly earnings announcement on Wednesday, January 24th 2024.
View our CNS earnings forecast.

Cohen & Steers, Inc. (NYSE:CNS) issued its earnings results on Thursday, October, 19th. The asset manager reported $0.70 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.74 by $0.04. The asset manager had revenue of $123.74 million for the quarter. Cohen & Steers had a trailing twelve-month return on equity of 41.24% and a net margin of 26.57%. The business's quarterly revenue was down 11.6% on a year-over-year basis. During the same period in the previous year, the firm posted $0.92 EPS.

Cohen & Steers declared a quarterly dividend on Thursday, November 2nd. Shareholders of record on Monday, November 13th will be paid a dividend of $0.57 per share on Tuesday, November 28th. This represents a $2.28 annualized dividend and a yield of 3.91%. The ex-dividend date of this dividend is Friday, November 10th.
Read our dividend analysis for CNS.

Cohen & Steers (NYSE:CNS) pays an annual dividend of $2.28 per share and currently has a dividend yield of 3.99%. CNS has a dividend yield higher than 75% of all dividend-paying stocks, making it a leading dividend payer. The company has been increasing its dividend for 14 consecutive years, indicating the company has a strong committment to maintain and grow its dividend. The dividend payout ratio is 85.71%. Payout ratios above 75% are not desirable because they may not be sustainable.
Read our dividend analysis for CNS.

ETFs with the largest weight of Cohen & Steers (NYSE:CNS) stock in their portfolio include Adaptive Core ETF (RULE), Gabelli Financial Services Opportunities ETF (GABF), SPDR S&P Capital Markets ETF (KCE), WisdomTree U.S. SmallCap Quality Dividend Growth Fund (DGRS), ProShares Russell 2000 Dividend Growers ETF (SMDV), ALPS O'Shares U.S. Small-Cap Quality Dividend ETF (OUSM), Royce Quant Small-Cap Quality Value ETF (SQLV) and WisdomTree U.S. SmallCap Dividend Fund (DES).

11 employees have rated Cohen & Steers Chief Executive Officer Robert H. Steers on Glassdoor.com. Robert H. Steers has an approval rating of 51% among the company's employees. This puts Robert H. Steers in the bottom 25% of approval ratings compared to other CEOs of publicly-traded companies.

Based on aggregate information from My MarketBeat watchlists, some companies that other Cohen & Steers investors own include AT&T (T), Energy Transfer (ET), Enterprise Products Partners (EPD), Ford Motor (F), Las Vegas Sands (LVS), Verizon Communications (VZ), Advanced Micro Devices (AMD), Cisco Systems (CSCO), Altria Group (MO) and Tanger Factory Outlet Centers (SKT).

Cohen & Steers' stock is owned by a variety of retail and institutional investors. Top institutional investors include Bamco Inc. NY (4.58%), Victory Capital Management Inc. (3.37%), Copeland Capital Management LLC (2.08%), Morgan Stanley (2.05%), Boston Trust Walden Corp (1.89%) and Charles Schwab Investment Management Inc. (1.37%). Insiders that own company stock include Elena Dulik, Martin Cohen and Richard P Simon.
View institutional ownership trends.

Shares of CNS stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.